Marshall Wace LLP raised its stake in shares of Olaplex Holdings, Inc. (NASDAQ:OLPX - Free Report) by 620.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,001,339 shares of the company's stock after buying an additional 862,419 shares during the period. Marshall Wace LLP owned 0.15% of Olaplex worth $1,732,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. Charles Schwab Investment Management Inc. lifted its position in Olaplex by 0.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,075,688 shares of the company's stock worth $1,861,000 after acquiring an additional 9,661 shares during the last quarter. Belpointe Asset Management LLC lifted its position in shares of Olaplex by 23.6% during the 4th quarter. Belpointe Asset Management LLC now owns 61,461 shares of the company's stock worth $106,000 after purchasing an additional 11,724 shares during the last quarter. Chemistry Wealth Management LLC bought a new stake in Olaplex during the 4th quarter valued at approximately $25,000. Parkside Financial Bank & Trust grew its holdings in Olaplex by 290.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 21,395 shares of the company's stock valued at $37,000 after buying an additional 15,911 shares during the last quarter. Finally, Wells Fargo & Company MN increased its position in Olaplex by 27.6% in the 4th quarter. Wells Fargo & Company MN now owns 81,972 shares of the company's stock worth $142,000 after buying an additional 17,726 shares during the period. Institutional investors own 87.37% of the company's stock.
Insider Buying and Selling at Olaplex
In other news, insider Trisha L. Fox sold 26,526 shares of the company's stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $1.44, for a total value of $38,197.44. Following the sale, the insider now owns 461,548 shares of the company's stock, valued at approximately $664,629.12. This represents a 5.43 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, General Counsel John C. Duffy sold 35,013 shares of Olaplex stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $1.44, for a total transaction of $50,418.72. Following the transaction, the general counsel now directly owns 348,630 shares of the company's stock, valued at $502,027.20. This represents a 9.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 73,269 shares of company stock valued at $103,161. 4.20% of the stock is currently owned by corporate insiders.
Olaplex Price Performance
Shares of NASDAQ:OLPX traded up $0.06 during midday trading on Friday, reaching $1.37. 790,732 shares of the company's stock were exchanged, compared to its average volume of 2,160,164. The firm has a market capitalization of $912.09 million, a PE ratio of 22.84 and a beta of 2.39. The company's 50 day simple moving average is $1.31 and its two-hundred day simple moving average is $1.61. Olaplex Holdings, Inc. has a 12 month low of $1.01 and a 12 month high of $2.77. The company has a debt-to-equity ratio of 0.73, a quick ratio of 10.32 and a current ratio of 11.84.
Analyst Ratings Changes
Several brokerages have recently issued reports on OLPX. Barclays raised their price objective on shares of Olaplex from $1.50 to $1.70 and gave the stock an "equal weight" rating in a research note on Wednesday, March 5th. Piper Sandler boosted their price objective on shares of Olaplex from $1.50 to $2.00 and gave the stock a "neutral" rating in a report on Monday, January 6th. Finally, Telsey Advisory Group reiterated a "market perform" rating and issued a $2.00 target price on shares of Olaplex in a research note on Friday.
Check Out Our Latest Research Report on OLPX
About Olaplex
(
Free Report)
Olaplex Holdings, Inc develops, manufactures, and sells hair care products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It provides hair care products to professional hair salons, retailers, and everyday consumers.
Read More

Before you consider Olaplex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Olaplex wasn't on the list.
While Olaplex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.